PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves’ orbitopathy
ObjectivesTransforming growth factor β1 (TGFβ1)-interleukin 11 (IL11) is a newly found critical signaling pathway in fibrotic diseases such as Graves’ orbitopathy (GO). It has now been confirmed that enhanced glycolysis plays a key role in the pathogenesis of GO. However, little is known about the r...
Saved in:
| Main Authors: | Zhiyu Peng, Rui Huang, Lu Gan, Jinghan Wang, Xiaofeng Li, Jie Ding, Yinan Han, Jihong Wu, Kang Xue, Jie Guo, Rui Zhang, Jiang Qian, Ruiqi Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1537365/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Key indicators for guiding tocilizumab therapy to prevent orbital decompression surgery in hormone-resistant dysthyroid optic neuropathy
by: Wenjun Shu, et al.
Published: (2025-05-01) -
Identification and verification of the optimal feature genes of ferroptosis in thyroid-associated orbitopathy
by: Xuemei Li, et al.
Published: (2024-12-01) -
Evolving techniques in orbital decompression of thyroid orbitopathy
by: Manuel O. Palmero, MD, et al.
Published: (2007-06-01) -
A randomized controlled trial on the effect of hydroxychloroquine in mild Graves’ orbitopathy (GO-HCQ): study protocol
by: Chia-Hung Lin, et al.
Published: (2025-08-01) -
Inactive Graves’ orbitopathy: to treat or not to treat?
by: O. G. Panteleeva, et al.
Published: (2023-03-01)